Valuable insights
1.Digital Device for Insomnia Therapy: Élobateur Insomnie functions as a medical device offering digital therapeutic intervention for sleep disorders, specifically targeting insomnia treatment through structured programs.
2.CBT-I Delivery Mechanism: The solution provides Cognitive Behavioral Therapy for Insomnia (CBT-I), utilizing a structured approach to help users understand underlying mechanisms and adopt proven techniques for restorative sleep.
3.Partnership Based on Proven Efficacy: The collaboration with HelloBetter was initiated after observing the application's demonstrated value and effectiveness, substantiated by rigorous scientific studies conducted in the German market.
4.Strong Clinical Validation: The efficacy of the Élobateur Insomnie device has been clinically validated through five separate randomized controlled trials, confirming its ability to produce measurable therapeutic outcomes.
5.Unique Prescription Access Requirement: A distinctive feature of this program involves requiring participants to consult their general practitioner to obtain a formal prescription before accessing the digital therapy.
6.Targeted Pilot Population: The initial testing phase involves approximately 250 patients, primarily drawn from the public service sector, including educators and nursing professionals, who frequently experience insomnia issues.
7.Twelve-Week Therapeutic Program: The application guides users through a 12-week program where new concepts are introduced weekly, facilitating a deeper understanding of insomnia and skill acquisition.
8.Bypassing Traditional Wait Times: Digital delivery significantly reduces access barriers; in-person CBT-I can involve waiting periods up to six months before seeing a qualified health professional.
9.Immediate Activation Post-Prescription: Once the prescription is secured, activation of the digital solution is nearly instantaneous, with fifty percent of users gaining access within the first 24 hours.
10.Measuring Return on Investment: A key objective involves quantifying the return on investment by monitoring factors such as decreased reliance on sleep medication and overall patient improvement.
11.Goal of Social Security Reimbursement: If Élobateur gains recognition as a Digital Therapy (DTX), the subsequent goal is securing reimbursement from the social security system.
12.Universal Accessibility Through Mutual Insurance: Upon social security coverage, the mutual insurance provider intends to cover the complementary portion, effectively making the treatment fully reimbursed and accessible to all members.
Introduction to the Digital Insomnia Solution
Élobateur Insomnie is defined as a medical device designed with a therapeutic digital purpose. Concretely, this solution offers Cognitive Behavioral Therapy for Insomnia (CBT-I). The decision to collaborate with the HelloBetter application stemmed from the significant value and proven efficacy demonstrated by their platform in Germany. Scientific studies were thoroughly reviewed, confirming that the proposed solution possesses a high degree of seriousness and reliability.
Validation Through Scientific Trials
The clinical effectiveness of the Élobateur Insomnie device has been rigorously evaluated across five randomized controlled trials. These studies provided the necessary validation regarding the device's clinical efficacy. An original aspect of this deployment strategy, differing from standard practices, involved instructing members to seek a prescription from their general practitioner to obtain access to the digital therapeutic.
The idea that was quite original compared to what is usually done was to ask members to go see their general practitioner to be able to obtain a prescription.
- Pilot test group size: 250 patients.
- Primary affected demographic: Public service employees (teachers, nurses).
- General prevalence of insomnia in France: Around 10%.
Program Structure and Access Efficiency
The application functions as a comprehensive program spanning 12 weeks. Each week introduces a new concept designed to help users better understand the underlying mechanisms of insomnia. Subsequently, participants are guided to appropriate and proven techniques necessary for achieving restorative nights. This contrasts sharply with traditional therapy delivery methods.
Immediate Activation Following Prescription
To access Élobateur Insomnie, consulting a treating physician for an official prescription is the necessary step. The subsequent activation process occurs almost immediately. Fifty percent of users successfully activate their access within 24 hours of receiving the prescription, demonstrating high responsiveness compared to lengthy traditional waitlists.
To access Élobateur Insomnie, it is sufficient to consult their treating physician who can establish a prescription for the device and then activation occurs almost immediately.
Financial Objectives and Reimbursement Strategy
The primary objective for the organization involves meticulously measuring the return on investment (ROI). This measurement focuses on tangible outcomes, such as observing a reduction in the consumption of sleep medications and confirming that individuals experience overall well-being improvements, indicating successful insomnia treatment.
- Reduction in prescribed medication usage.
- Measurable improvement in patient quality of life.
- Successful resolution of insomnia symptoms.
Path Towards Full Reimbursement
If Élobateur successfully achieves recognition as a DTX (Digital Therapy), the subsequent strategic goal is securing reimbursement coverage from the social security system. When this occurs, the mutual insurance provider will fulfill its customary role by reimbursing the complementary portion of the cost. This final step ensures the solution becomes completely reimbursed and accessible to every member without out-of-pocket expenses.
Useful links
These links were generated based on the content of the video to help you deepen your knowledge about the topics discussed.